Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Reporting of transactions with ALK-Abelló A/S' B-shares and associated securities by person closely associated with person discharging managerial responsibly


Posted on: 11 Dec 17

Copenhagen, 2017-12-11 16:29 CET (GLOBE NEWSWIRE) --  

With reference to company announcement no. 35/2017 and no. 36/2017 regarding offering, pricing and completing of the offering of new shares in ALK-Abelló A/S, company registration no. (CVR) 63 71 79 16 ("ALK"), ALK hereby, pursuant to the Market Abuse Regulation article 19, notifies information of the following transaction made by Lundbeckfond Invest A/S who is closely associated with persons discharging managerial responsibilities with ALK. 

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 

1. Details of the Reporting Person / Closely Associated Person
a) Name Lundbeckfond Invest A/S
2. Reason for the notification
a) Position/status Closely associated with board member, Lene Skole
b) Initial notification/amendment Initial notification
3. Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name ALK-Abelló A/S
b) LEI code 529900SGCREUZCZ7P020
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of trans-action; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instru-ment AA-shares and B-shares
 
DK0060027142 (B-shares)
b) Nature of the transaction Subscription of new AA- shares and B-shares
c) Price(s) and volume(s) Price(s) Volume(s)
  AA-shares DKK 63,529,680 92,072
  B-shares DKK 217,965,480 315,892
d) Aggregated information and aggregated volume price 407,964 shares
DKK 281,495,160
e) Date of transaction 2017-12-11
f) Place of the transaction NASDAQ Copenhagen

  

ALK-Abelló A/S
 

For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

GlobeNewswire
globenewswire.com

Last updated on: 11/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.